APA (7th ed.) Citation

Kamaraju, S., Fowler, A. M., Tarima, S., Chaudhary, L. N., Burkard, M. E., Giever, T., . . . Wisinski, K. (2025). A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer. Clinical breast cancer, 25(3), 251-260. https://doi.org/10.1016/j.clbc.2024.11.019

Chicago Style (17th ed.) Citation

Kamaraju, Sailaja, et al. "A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer." Clinical Breast Cancer 25, no. 3 (2025): 251-260. https://doi.org/10.1016/j.clbc.2024.11.019.

MLA (9th ed.) Citation

Kamaraju, Sailaja, et al. "A Phase II Trial of Onapristone and Fulvestrant for Patients With ER+ and HER2- Metastatic Breast Cancer." Clinical Breast Cancer, vol. 25, no. 3, 2025, pp. 251-260, https://doi.org/10.1016/j.clbc.2024.11.019.